Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse

Neuroscience

Volumn 156, Issue 4, 2008, Pages 1111-1117

  Wei, G ^a   Kibler, K K ^a   Koehler, R C ^a   Maruyama, T ^b   Narumiya, S ^c   Dore S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ONO PHARMACEUTICAL CO   (Japan)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

cerebral ischemia; G protein coupled receptors; hippocampus; prostaglandins; stroke

Indexed keywords

PROSTACYCLIN RECEPTOR;

ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL DEATH; CELL DENSITY; CELL SURVIVAL; COMMON CAROTID ARTERY; CONTROLLED STUDY; FOREBRAIN; GENE DELETION; GENOTYPE; HIPPOCAMPUS; MALE; MOUSE; NERVE INJURY; NONHUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REPERFUSION; SHAM PROCEDURE;

ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN ISCHEMIA; CAROTID ARTERY DISEASES; CELL DEATH; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PYRAMIDAL CELLS; RECEPTORS, EPOPROSTENOL; REPERFUSION;

EID: 53949084891     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.07.073     Document Type: Article

References (65)

1. Abella B.S., Zhao D., Alvarado J., Hamann K., Vanden Hoek T.L., and Becker L.B. Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation 109 (2004) 2786-2791
2. Ahmad A.S., Ahmad M., de Brum-Fernandes A.J., and Doré S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 1066 (2005) 71-77
3. Ahmad A.S., Saleem S., Ahmad M., and Doré S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89 (2006) 265-270
4. Anwaar I., Gottsater A., Ohlsson K., Mattiasson I., and Lindgarde F. Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis 8 (1998) 310-317
5. Awad I., Little J.R., Lucas F., Skrinska V., Slugg R., and Lesser R.P. Treatment of acute focal cerebral ischemia with prostacyclin. Stroke 14 (1983) 203-209
6. Bath P.M. Prostacyclin and analogues for acute ischaemic stroke. Cochrane Database Syst Rev 3 (2004) CD000177
7. Beischer W., Dembski J.C., Gruss J.D., Hofgartner F., Horsch A., Horsch S., Kuhlmann H.W., Loose D.A., Mietaschk A., Schwilden E.D., Spengel F., Spitzer W., Staben P., Stallkamp B., Sturzebecher C.S., Tokhi M., and von Bilderling P. Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV. DAWID Study Group. Vasa 27 (1998) 15-19
8. Boie Y., Rushmore T.H., Darmon-Goodwin A., Grygorczyk R., Slipetz D.M., Metters K.M., and Abramovitz M. Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem 269 (1994) 12173-12178
9. Breyer R.M., Bagdassarian C.K., Myers S.A., and Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41 (2001) 661-690
10. Castillo J., Leira R., Garcia M.M., Serena J., Blanco M., and Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 35 (2004) 520-526
11. Catella-Lawson F. Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects. Neurology 57 (2001) S5-S7
12. Ciuffetti G., Sokola E., Lombardini R., Pasqualini L., Pirro M., and Mannarino E. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication. Kardiol Pol 59 (2003) 197-204
13. Cui Y., Kataoka Y., Satoh T., Yamagata A., Shirakawa N., Watanabe Y., Suzuki M., Yanase H., and Kataoka K. Protective effect of prostaglandin I(2) analogs on ischemic delayed neuronal damage in gerbils. Biochem Biophys Res Commun 265 (1999) 301-304
14. Dohi S. [Effects of a intravenous or subarachnoid PGI2 analog (OP-41483) on cerebral and spinal cord blood flow in dogs]. Masui 36 (1987) 1790-1795
15. Doré S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., and Andreasson K. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol 54 (2003) 155-162
16. Dougherty Jr. J.H., Levy D.E., Rawlinson D.G., Ruff R., Weksler B.B., and Plum F. Experimental cerebral ischemia produced by extracranial vascular injury: protection with indomethacin and prostacyclin. Neurology 32 (1982) 970-974
17. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78 (1998) 53-97
18. Gardenfors F., Nilsson A., Ungerstedt U., and Nordstrom C.H. Adverse biochemical and physiological effects of prostacyclin in experimental brain oedema. Acta Anaesthesiol Scand 48 (2004) 1316-1321
19. Gillingwater T.H., Haley J.E., Ribchester R.R., and Horsburgh K. Neuroprotection after transient global cerebral ischemia in Wld(s) mutant mice. J Cereb Blood Flow Metab 24 (2004) 62-66
20. Gryglewski R.J., Nowak S., Kostka-Trabka E., Kusmiderski J., Dembinska-Kiec A., Bieron K., Basista M., and Blaszczyk B. Treatment of ischaemic stroke with prostacyclin. Stroke 14 (1983) 197-202
21. Huang Y., and McNamara J.O. Ischemic stroke: "acidotoxicity" is a perpetrator. Cell 118 (2004) 665-666
22. Iadecola C., Forster C., Nogawa S., Clark H.B., and Ross M.E. Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol (Berl) 98 (1999) 9-14
23. Karasawa Y., Hitomi T., Komiyama H., Isobe Y., Kobayashi T., Yoshida S., Nakaike S., and Araki H. Effect of TTC-909 in a middle cerebral artery thrombosis model in stroke-prone spontaneously hypertensive rats. Eur J Pharmacol 449 (2002) 127-133
24. Karasawa Y., Komiyama H., Yoshida S., Hino N., Katsuura Y., Nakaike S., and Araki H. Effect of TTC-909 on cerebral infarction following permanent occlusion of the middle cerebral artery in stroke prone spontaneously hypertensive rats. J Pharmacol Sci 91 (2003) 305-312
25. Kawahara N., Kawai K., Toyoda T., Nakatomi H., Furuya K., and Kirino T. Cardiac arrest cerebral ischemia model in mice failed to cause delayed neuronal death in the hippocampus. Neurosci Lett 322 (2002) 91-94
26. Kitagawa K., Matsumoto M., Tsujimoto Y., Ohtsuki T., Kuwabara K., Matsushita K., Yang G., Tanabe H., Martinou J.C., Hori M., and Yanagihara T. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 29 (1998) 2616-2621
27. Kitagawa K., Matsumoto M., Yang G., Mabuchi T., Yagita Y., Hori M., and Yanagihara T. Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J Cereb Blood Flow Metab 18 (1998) 570-579
28. Kobayashi T., Tahara Y., Matsumoto M., Iguchi M., Sano H., Murayama T., Arai H., Oida H., Yurugi-Kobayashi T., Yamashita J.K., Katagiri H., Majima M., Yokode M., Kita T., and Narumiya S. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 114 (2004) 784-794
29. Lau C.S., McLaren M., Saniabadi A., Scott N., and Belch J.J. The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis-a preliminary study. Clin Exp Rheumatol 9 (1991) 271-273
30. Leffler C.W., Mirro R., Armstead W.M., Busija D.W., and Thelin O. Prostanoid synthesis and vascular responses to exogenous arachidonic acid following cerebral ischemia in piglets. Prostaglandins 40 (1990) 241-248
31. Leffler C.W., Smith J.S., Edrington J.L., Zuckerman S.L., and Parfenova H. Mechanisms of hypoxia-induced cerebrovascular dilation in the newborn pig. Am J Physiol 272 (1997) H1323-H1332
32. Maeda K., Hata R., and Hossmann K.A. Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice. Neuroreport 9 (1998) 1317-1319
33. 2 analog, TEI-7165, on ischemic neuronal damage in gerbils. Brain Res 769 (1997) 321-328
34. Moncada S. Eighth Gaddum memorial lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. Br J Pharmacol 76 (1982) 3-31
35. Murakami K., Kondo T., Epstein C.J., and Chan P.H. Overexpression of CuZn-superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice. Stroke 28 (1997) 1797-1804
36. Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., Ichikawa A., Aze Y., Tanaka T., Yoshida N., Ueno A., Oh-ishi S., and Narumiya S. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388 (1997) 678-682
37. Nakagawa O., Tanaka I., Usui T., Harada M., Sasaki Y., Itoh H., Yoshimasa T., Namba T., Narumiya S., and Nakao K. Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation 90 (1994) 1643-1647
38. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., and Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A 95 (1998) 10954-10959
39. Narumiya S., and FitzGerald G.A. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108 (2001) 25-30
40. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
41. Ocal A., Kiris I., Erdinc M., Peker O., Yavuz T., and Ibrisim E. Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension. Tohoku J Exp Med 207 (2005) 51-58
42. Ohtaki H., Mori S., Nakamachi T., Dohi K., Yin L., Endo S., Okada Y., and Shioda S. Evaluation of neuronal cell death after a new global ischemia model in infant mice. Acta Neurochir Suppl 86 (2003) 97-100
43. Olsson T., Nygren J., Hakansson K., Lundblad C., Grubb A., Smith M.L., and Wieloch T. Gene deletion of cystatin C aggravates brain damage following focal ischemia but mitigates the neuronal injury after global ischemia in the mouse. Neuroscience 128 (2004) 65-71
44. Olsson T., Wieloch T., and Smith M.L. Brain damage in a mouse model of global cerebral ischemia. Effect of NMDA receptor blockade. Brain Res 982 (2003) 260-269
45. Orfeo T., Doherty J.M., Adey G., Penar P.L., and Shatos M.A. Sublethal percussion trauma in vitro causes a persisting derangement in the nonthrombogenic properties of brain endothelial cells. J Trauma 37 (1994) 347-357
46. Regan J.W., Bailey T.J., Pepperl D.J., Pierce K.L., Bogardus A.M., Donello J.E., Fairbairn C.E., Kedzie K.M., Woodward D.F., and Gil D.W. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol Pharmacol 46 (1994) 213-220
47. Stroke Therapy Academic Industry Roundtable. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32 (2001) 1598-1606
48. Sairanen T., Ristimaki A., Karjalainen-Lindsberg M.L., Paetau A., Kaste M., and Lindsberg P.J. Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 43 (1998) 738-747
49. Satoh T., Ishikawa Y., Kataoka Y., Cui Y., Yanase H., Kato K., Watanabe Y., Nakadate K., Matsumura K., Hatanaka H., Kataoka K., Noyori R., and Suzuki M. CNS-specific prostacyclin ligands as neuronal survival-promoting factors in the brain. Eur J Neurosci 11 (1999) 3115-3124
50. Scotland R.S., Madhani M., Chauhan S., Moncada S., Andresen J., Nilsson H., Hobbs A.J., and Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 111 (2005) 796-803
51. 3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther 286 (1998) 1094-1102
52. Sheng H., Laskowitz D.T., Pearlstein R.D., and Warner D.S. Characterization of a recovery global cerebral ischemia model in the mouse. J Neurosci Methods 88 (1999) 103-109
53. Smith W.L., Marnett L.J., and DeWitt D.L. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 49 (1991) 153-179
54. Sorimachi T., Abe H., Takeuchi S., and Tanaka R. Neuronal damage in gerbils caused by intermittent forebrain ischemia. J Neurosurg 91 (1999) 835-842
55. Sorimachi T., Abe H., Takeuchi S., and Tanaka R. Ischemic depolarization monitoring: evaluation of protein synthesis in the hippocampal CA1 after brief unilateral ischemia in a gerbil model. J Neurosurg 97 (2002) 104-111
56. Stoll G., Jander S., and Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56 (1998) 149-171
57. Takamatsu H., Tsukada H., Watanabe Y., Cui Y., Kataoka Y., Hosoya T., and Suzuki M. Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia. Brain Res 925 (2002) 176-182
58. Taoka Y., Okajima K., Uchiba M., Murakami K., Harada N., Johno M., Naruo M., Okabe H., and Takatsuki K. Reduction of spinal cord injury by administration of iloprost, a stable prostacyclin analog. J Neurosurg 86 (1997) 1007-1011
59. Thel M.C., and O'Connor C.M. Cardiopulmonary resuscitation: historical perspective to recent investigations. Am Heart J 137 (1999) 39-48
60. Uchiyama-Tsuyuki Y., Kawashima K., Araki H., and Otomo S. Prostacyclin analogue TTC-909 reduces memory impairment in rats with cerebral embolism. Pharmacol Biochem Behav 52 (1995) 555-559
61. Whittle B.J., Moncada S., and Vane J.R. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins 16 (1978) 373-388
62. Willis A.P., and Leffler C.W. NO and prostanoids: age dependence of hypercapnia and histamine-induced dilations of pig pial arterioles. Am J Physiol 277 (1999) H299-H307
63. Wright D.H., Abran D., Bhattacharya M., Hou X., Bernier S.G., Bouayad A., Fouron J.C., Vazquez-Tello A., Beauchamp M.H., Clyman R.I., Peri K., Varma D.R., and Chemtob S. Prostanoid receptors: ontogeny and implications in vascular physiology. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1343-R1360
64. Yonekura I., Kawahara N., Nakatomi H., Furuya K., and Kirino T. A model of global cerebral ischemia in C57 BL/6 mice. J Cereb Blood Flow Metab 24 (2004) 151-158
65. Zola-Morgan S., Squire L.R., and Amaral D.G. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 6 (1986) 2950-2967